Picture of US Physical Therapy logo

USPH — US Physical Therapy News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

US Physical Therapy Inc expected to post earnings of 56cents a share - Earnings Preview

* US Physical Therapy Inc  USPH.N   USPH.K  is expected
to show a
rise in quarterly revenue when it reports  results on November
3. 
    * The Houston Texas-based  company is expected to report  a
9.8% increase in revenue to $138.229 million from $125.89
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for US Physical Therapy
Inc
is for earnings of 56 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for US Physical
Therapy Inc is $103.5​, above​ its last closing price of $88.80.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  0.95        0.95       0.90      Missed  -4.9
 Mar. 31 2022  0.63        0.63       0.65      Beat    2.8
 Dec. 31 2021  0.69        0.69       0.72      Beat    4.7​
 Sep. 30 2021  0.78        0.78       0.85      Beat    9.3
 ​​Jun.        0.74        0.73       0.96      Beat    32.2
 30 2021                                                
 Mar. 31 2021  0.47        0.47       0.64      Beat    36.2​
 Dec. 31 2020  0.82        0.83       0.85      Beat    2.2
 Sep. 30 2020  0.50        0.51       0.85      Beat    66
 This summary was machine generated November 1 at 18:38 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on US Physical Therapy

See all news